Proto Script Pharmaceutical (Proto Script Pharmaceutical) Debt-to-Revenue : 0.37 (As of Sep. 2017)

View and export this data going back to 2011. Start your Free Trial

What is Proto Script Pharmaceutical Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Proto Script Pharmaceutical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2017 was $0.37 Mil. Proto Script Pharmaceutical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2017 was $0.00 Mil. Proto Script Pharmaceutical's annualized Revenue for the quarter that ended in Sep. 2017 was $1.01 Mil. Proto Script Pharmaceutical's annualized Debt-to-Revenue for the quarter that ended in Sep. 2017 was 0.37.

Proto Script Pharmaceutical Debt-to-Revenue Historical Data

The historical data trend for Proto Script Pharmaceutical's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proto Script Pharmaceutical Debt-to-Revenue Chart

Proto Script Pharmaceutical Annual Data

Trend

May12

May13

May14

May15

May16

Debt-to-Revenue

N/A

Proto Script Pharmaceutical Quarterly Data
	Nov12	Feb13	May13	Aug13	Nov13	Feb14	May14	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Sep16	Dec16	Mar17	Jun17	Sep17
Debt-to-Revenue	Get a 7-Day Free Trial															0.10	0.13	0.13	0.52	0.37

Competitive Comparison of Proto Script Pharmaceutical's Debt-to-Revenue

For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proto Script Pharmaceutical's Debt-to-Revenue Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Proto Script Pharmaceutical's Debt-to-Revenue falls into.

Proto Script Pharmaceutical Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Proto Script Pharmaceutical's Debt-to-Revenue for the fiscal year that ended in May. 2016 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	N/A
	=	N/A

Proto Script Pharmaceutical's annualized Debt-to-Revenue for the quarter that ended in Sep. 2017 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.373	+	0)	/	1.008
	=	0.37

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2017) Revenue data.

Proto Script Pharmaceutical Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Proto Script Pharmaceutical's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Proto Script Pharmaceutical Corp (OTCPK:PSCR) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730

Website

http://www.psphomecare.com

Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Headlines

No Headlines